Find HDV and Determine Its Status in Turkey "SITU(HD)VATION"
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 20,000
- Locations
- 2
- Primary Endpoint
- The frequency of HDV in certain regions of Southern Anatolia
Study Overview
Brief Summary
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
Detailed Description
Study Objectives:
The aim of these study to determine the prevalence of HDV infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing HBV, HDV, HCV, and HIV infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
Primary Objectives:
To reveal the status of HDV infection in Turkey within the framework of the national hepatitis elimination program by providing training to family physicians.
Second Objectives:
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adults (Age≥18)
- •Being HBsAg positive for at least six months
- •Being a citizen of the Republic of Türkiye
Exclusion Criteria
- •There are no exclusion criteria in this study.
Outcomes
Primary Outcomes
The frequency of HDV in certain regions of Southern Anatolia
Time Frame: 01.04.2024-30.09.2024
The primary endpoint of this study is to determine the frequency of HDV in certain regions of Southern Anatolia, and the virological and liver fibrosis status of patients with HDV infection.
Secondary Outcomes
- The rate of HIV and HCV co-infection in HDV positive patients(01.04.2024-30.09.2024)
Investigators
Yaşar Bayındır, MD
Chief Physician, Prof. Dr., M.D.
Guven Health Group